LGALS14, galectin 14, 56891

N. diseases: 35; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C3160897
Disease: Opioid-Induced Constipation
Opioid-Induced Constipation
0.010 Biomarker phenotype BEFREE Lubiprostone is a ClC-2 chloride channel activator approved for the treatment of chronic idiopathic constipation (CIC) and opioid-induced constipation (OIC) in adults and irritable bowel syndrome with constipation (IBS-C) in women. 28849329 2017